CME Group (CME) PT Raised to $284 at UBS
- Wall Street ends first day of third quarter with solid rebound
- Tesla (TSLA) Delivered 254,695 EV Units in Q2, Below Consensus
- Goldman Sachs Warns Clients of More Equity Market Losses in Second Half of 2022
- Kohl's (KSS) Falls 15% After Ending Sale Talks With Franchise Group and Issuing Q2 Warning
- General Motors Warns It Has 95k Vehicles in Inventory Without Certain Components
UBS analyst Alex Kromm raised the price target on CME Group (NASDAQ: CME) to $284.00 (from $269.00) while maintaining a Buy rating.
You May Also Be Interested In
- Larsen & Toubro Infotech Ltd (LT:IN) (LTOUF) PT Lowered to INR3,500 at JPMorgan
- Bumi Serpong Damai (BSDE:IJ) (BSPDF) PT Lowered to IDR1,390 at Citi
- Tata Consultancy Services Ltd. (TCS:IN) PT Lowered to INR2,800 at JPMorgan
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!